Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation

• Volkert A. L. Huurman ,

  Contributed equally to this work with: Volkert A. L. Huurman, Robert Hilbrands

  Affiliations Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands, Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands, JDRF Center for Beta Cell Therapy in Diabetes, Brussels, Belgium

  ⨯
• Robert Hilbrands ,

  Contributed equally to this work with: Volkert A. L. Huurman, Robert Hilbrands

  Affiliations Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium, JDRF Center for Beta Cell Therapy in Diabetes, Brussels, Belgium

  ⨯
• Gabriëlle G. M. Pinkse,

  Affiliations Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands, JDRF Center for Beta Cell Therapy in Diabetes, Brussels, Belgium

  ⨯
• Pieter Gillard,

  Affiliations Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium, Laboratory for Experimental Medicine & Endocrinology (LEGENDO), University Hospital Gasthuisberg, Catholic University of Leuven-KUL, Leuven, Belgium, JDRF Center for Beta Cell Therapy in Diabetes, Brussels, Belgium

  ⨯
• Gaby Duinkerken,

  Affiliations Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands, JDRF Center for Beta Cell Therapy in Diabetes, Brussels, Belgium

  ⨯
• Pieter van de Linde,

  Affiliations Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands, Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands, JDRF Center for Beta Cell Therapy in Diabetes, Brussels, Belgium

  ⨯
• Petronella M. W. van der Meer-Prins,

  Affiliations Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands, JDRF Center for Beta Cell Therapy in Diabetes, Brussels, Belgium

  ⨯
• Minke F. J. Versteeg-van der Voort Maarschalk,

  Affiliations Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands, JDRF Center for Beta Cell Therapy in Diabetes, Brussels, Belgium

  ⨯
• Koen Verbeeck,

  Affiliations Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium, JDRF Center for Beta Cell Therapy in Diabetes, Brussels, Belgium

  ⨯
• Behrooz Z. Alizadeh,

  Affiliations Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands, JDRF Center for Beta Cell Therapy in Diabetes, Brussels, Belgium

  ⨯
• Chantal Mathieu,

  Affiliations Laboratory for Experimental Medicine & Endocrinology (LEGENDO), University Hospital Gasthuisberg, Catholic University of Leuven-KUL, Leuven, Belgium, JDRF Center for Beta Cell Therapy in Diabetes, Brussels, Belgium

  ⨯
• Frans K. Gorus,

  Affiliations Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium, JDRF Center for Beta Cell Therapy in Diabetes, Brussels, Belgium

  ⨯
• Dave L. Roelen,

  Affiliations Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands, JDRF Center for Beta Cell Therapy in Diabetes, Brussels, Belgium

  ⨯
• Frans H. J. Claas,

  Affiliations Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands, JDRF Center for Beta Cell Therapy in Diabetes, Brussels, Belgium

  ⨯
• Bart Keymeulen,

  Affiliations Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium, JDRF Center for Beta Cell Therapy in Diabetes, Brussels, Belgium

  ⨯
• Daniel G. Pipeleers,

  Affiliations Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium, JDRF Center for Beta Cell Therapy in Diabetes, Brussels, Belgium

  ⨯
•  [ ... ],
• Bart O. Roep

  * E-mail: boroep@lumc.nl

  Affiliations Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands, JDRF Center for Beta Cell Therapy in Diabetes, Brussels, Belgium

  ⨯
• [ view all ]
• [ view less ]